BSE - Delayed Quote INR
Divi's Laboratories Limited (DIVISLAB.BO)
6,022.95
+64.60
+(1.08%)
At close: May 9 at 3:29:00 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
12,610,000
24,590,000
19,118,000
19,469,300
Investing Cash Flow
--
-2,690,000
-27,070,000
-21,949,200
751,300
Financing Cash Flow
--
-7,990,000
-7,970,000
-5,324,400
-348,900
End Cash Position
--
3,630,000
1,700,000
12,147,600
20,303,200
Capital Expenditure
--
-10,030,000
-4,730,000
-7,132,000
-9,101,900
Repayment of Debt
--
--
--
--
-332,800
Free Cash Flow
--
2,580,000
19,860,000
11,986,000
10,367,400
3/31/2021 - 3/25/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PPLPHARMA.BO Piramal Pharma Limited
207.90
+0.92%
ABBOTINDIA.BO Abbott India Limited
30,147.65
+0.42%
CIPLA.BO Cipla Limited
1,476.80
-0.67%
NATCOPHARM.BO NATCO Pharma Limited
809.55
+0.82%
CAPLIPOINT.NS Caplin Point Laboratories Limited
1,860.00
-2.20%
PPLPHARMA.NS Piramal Pharma Limited
208.99
+1.45%
CIPLA.NS Cipla Limited
1,477.00
-0.66%
LNTH Lantheus Holdings, Inc.
81.74
+1.62%